Document Detail


Differential Features Between Primary Ankylosing Spondylitis and Spondylitis Associated with Psoriasis and Inflammatory Bowel Disease.
MedLine Citation:
PMID:  21632676     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
OBJECTIVE: To describe differential characteristics of axial involvement in ankylosing spondylitis (AS) as compared with that seen in psoriatic arthritis (PsA) and inflammatory bowel disease (IBD) in a cohort of Ibero-American patients. METHODS: This study included 2044 consecutive patients with spondyloarthritis (SpA; ESSG criteria). Demographic, clinical, disease activity, functional ability, quality of life, work status, radiologic, and therapeutic data were evaluated and collected by RESPONDIA members from different Ibero-American countries between June and December 2006. Patients selected for analysis met modified New York criteria (mNY) for AS. RESULTS: A total of 1264 patients met the New York criteria for AS: 1072 had primary AS, 147 had psoriatic, and 45 had IBD-associated spondylitis. Median disease duration was comparable among the 3 patient groups. Patients with primary AS were significantly younger (p = 0.01) and presented a higher frequency of males (p = 0.01) than the other 2 groups. Axial manifestations such as inflammatory back pain and sacroiliac pain were significantly more frequent in patients with primary AS (p = 0.05) versus other groups, whereas frequency of dactylitis, enthesitis, and peripheral arthritis was more common in patients with psoriatic spondylitis (p = 0.05). Spinal mobility was significantly more limited in patients with primary AS versus the other 2 groups (p = 0.0001). Radiologic changes according to BASRI total score were equally significant in primary AS. Disease activity (BASDAI), functional ability (BASFI), and quality of life (ASQoL) scores were comparable in the 3 groups. CONCLUSION: Patients with primary AS had more severe axial involvement than those with spondylitis associated with psoriasis or IBD. Functional capacity, disease activity, and quality of life were comparable among the groups studied.
Authors:
Rodolfo Pérez Alamino; José A Maldonado Cocco; Gustavo Citera; Pablo Arturi; Janitzia Vazquez-Mellado; Percival D Sampaio-Barros; Diana Flores; Rubén Burgos-Vargas; Helena Santos; José E Chavez-Corrales; Daniel Palleiro; Miguel A Gutierrez; Elsa Vieira-Sousa; Fernando M Pimentel-Santos; Sergio Paira; Alberto Berman; Mario Moreno-Alvarez; Eduardo Collantes-Estevez
Related Documents :
8264906 - 123i-iodobenzamide-spect in 83 patients with de novo parkinsonism.
3821826 - Open microsurgical autograft of adrenal medulla to the right caudate nucleus in two pat...
21848856 - Faecal chitinase 3-like-1: a novel biomarker of disease activity in paediatric inflamma...
12614926 - Hypertrophy of imc of carotid artery in parkinson's disease is associated with l-dopa, ...
23232006 - Clinical characteristics of patients with tuberculosis-destroyed lung.
23507426 - Ker-egi, a new index of gait quantification based on electromyography.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-6-1
Journal Detail:
Title:  The Journal of rheumatology     Volume:  -     ISSN:  0315-162X     ISO Abbreviation:  -     Publication Date:  2011 Jun 
Date Detail:
Created Date:  2011-6-2     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7501984     Medline TA:  J Rheumatol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
From the Section of Rheumatology, Instituto de Rehabilitación Psicofísica, Buenos Aires, Argentina.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Secondary Osteoporosis in Men and Women: Clinical Challenge of an Unresolved Issue.
Next Document:  Serum MMP-3 Level as a Biomarker for Monitoring and Predicting Response to Etanercept Treatment in A...